Drug Approval | April 12, 2025
FDA approves Opdivo plus Yervoy as treatment metastatic colorectal cancer
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
_256_384.jpg)
Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas
Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Subscribe To Our Newsletter & Stay Updated
